ED Coding & Reimbursement Alert - 2006 Issue 1
PHARMACEUTICALS: FDA Stalled By Red Tape As Illegal Rx Market Booms
Subscribe or sign in to view the full article.
Article Overview
This article reviews federal concerns about the illegal importation of prescription drugs and the strain on FDA enforcement resources, along with CMS guidance directing state surveyors to examine long-term care facilities that obtain and dispense foreign drugs. It is relevant to compliance, pharmacy oversight, long-term care regulation, and federal agency policy discussions affecting imported medications and facility survey activity.
Why This Topic Matters
It helps readers understand the intersection of drug import enforcement, FDA admissibility procedures, and CMS survey oversight in settings where foreign-sourced medications may appear in routine care. The article is useful for compliance professionals, pharmacy leaders, long-term care administrators, and regulatory analysts tracking federal guidance.
What You Will Learn
- How federal agencies are responding to unlawful prescription-drug imports
- Why mail-facility inspection and admissibility processes are a compliance concern
- What CMS told state survey agencies about foreign drugs in long-term care facilities
- How imported-drug oversight affects pharmacy and facility survey practices
Who Should Read This
- Compliance professionals
- Pharmacy directors
- Long-term care administrators
- Regulatory affairs staff
- Healthcare attorneys
- Survey and inspection personnel
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com